Telemedicine has demonstrated significant benefits in T1D management, particularly in improving insulin adherence (patients receive real-time guidance on insulin dosing adjustments), sick day management (immediate access to medical advice prevents severe complications), and the reduction in unnecessary hospital visits (virtual care decreases emergency admissions). This evidence concerns the gene INS and type 1 diabetes mellitus.